NHS Expands Access to Life-Saving Blood Cancer Drug
Hundreds more blood cancer patients to receive Glofitamab (Columvi®) on the NHS, offering hope of a cure for aggressive DLBCL. A new lease of life for 300 people annually.
Hundreds more blood cancer patients to receive Glofitamab (Columvi®) on the NHS, offering hope of a cure for aggressive DLBCL. A new lease of life for 300 people annually.